Report of the Influenza Vaccination Program in Mexico (2006–2022) and Proposals for Its Improvement

Author:

Romero-Feregrino Rodrigo1234ORCID,Romero-Cabello Raúl124567,Rodríguez-León Mario Alfredo128ORCID,Rocha-Rocha Valeria Magali9ORCID,Romero-Feregrino Raúl1247ORCID,Muñoz-Cordero Berenice1210

Affiliation:

1. Asociación Mexicana de Vacunología, Mexico City 06760, Mexico

2. Instituto Para el Desarrollo Integral de la Salud (IDISA), Mexico City 06700, Mexico

3. Employer Sector CONCAMIN, Technical Council, Instituto Mexicano del Seguro Social (IMSS), Mexico City 06600, Mexico

4. Saint Luke School of Medicine, Mexico City 11000, Mexico

5. Department of Infectology, Hospital General de México, Mexico City 06720, Mexico

6. Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City 04360, Mexico

7. Academia Mexicana de Pediatría, Mexico City 03810, Mexico

8. School of Higher Studies (F.E.S.) Zaragoza, Universidad Nacional Autónoma de México (UNAM), Mexico City 09230, Mexico

9. School of Life and Health Sciences, Universidad Popular Autónoma del Estado de Puebla, Puebla 72410, Mexico

10. Department of Pediatrics, Hospital General de Cuajimalpa IMSS-Bienestar, Mexico City 05230, Mexico

Abstract

Background: Influenza has continued to be an important public health challenge, and the WHO recommends that countries consider vaccination for persons at high risk. Mexico has such a program, and we sought to determine its current situation. Material and Methods: This study has an ecological, longitudinal, and retrospective design based on secondary information on the acquisition and application of vaccines against influenza from official data from 2006 to 2022. Results: We found annual variability in the numbers of purchases and application of doses, with coverage of less than 90% of the total population every year; in addition, 17 million vaccines were not used in this period. Discussion: This study shows the situation of the program at the national level. Two institutions acquired fewer the vaccines, while one purchased more for its target population, but the necessary vaccinations were not acquired. On average, 1.7 million of the vaccines purchased annually were not used, but in some years, more vaccines were applied than were purchased in all of the institutions. We also observed that, between institutions, the vaccine coverage was very different, from 21% to 180%. On average, 6.2 million people were not vaccinated annually, between 16% and 22% of the target population, demonstrating low coverage. When we compared the coverage data that we calculated to the data published by the institutions, a great difference was observed. Conclusions: We found inconsistencies in the data, indicating their unreliability and potential disorganization within the program, as the target populations of each institution were not clear. In addition, the application data may have had reporting errors. Adequate coverage was not achieved, and the coverage was different from that reported in the official sources. We propose the implementation of different systems for control, evaluation, and access to the information of the program.

Funder

Sinovac Biotech (Singapore) Pte. Ltd.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3